AM580 is a RARα-specific agonist that is already proven to protect from diet-induced hyperlipidemia and hepatic lipid accumulation by inhibiting Apolipoprotein C-III (ApoC-III) [29,30]. This evidence concerns the gene RARA and hyperlipidemia.